Skip to Main Content

Paper Details

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.
Front Immunol
5
2023
Author NameAffiliation
Marian J A Groot KoerkampPrincess Maxima Center for Pediatric Oncology
Marian J A Groot KoerkampOncode Institute
Frank C P HolstegePrincess Maxima Center for Pediatric Oncology
Frank C P HolstegeCenter for Molecular Medicine, UMC Utrecht and Utrecht University
  • 1 - 4

Datasets

Release 1.2